5 reasons to be a Sanofi shareholder

Sanofi: a global healthcare leader

A leading player in Specialty Care, Vaccines, Consumer Healthcare and Emerging Markets.

€36,041m

2020
Company sales

€7,347m

2020
Business net income

€5.86

2020
Business EPS

Every day, more than 100,000 employees in more than 100 countries are committed to preventing diseases with vaccines, to offering innovative treatments and to supporting both those with rare diseases and the millions of people with chronic diseases.

Innovative Research and Development

A robust pipeline meeting unsatisfied medical needs which may support long-term growth.

Timelines

As of December 31, 2020

Solid financial performance

Value-creating acquisitions while maintaining financial discipline.

« We have been able to deliver margin improvement at the same time as accelerating investment in Specialty Care and Vaccines and absorbing new acquisitions »

Jean-Baptiste de Chatillon, EVP, Financial Director
2020 Full-Year Results Presentation

Consistent dividend increase for 27 years

Strong commitment to regular shareholder returns

Dividend

 

A responsible company

Focused on patients’ needs and committed to improving access to healthcare for all people across the globe.

responsibility

Discover Sanofi

Being a shareholder
Being a shareholder
Shareholder Handbook 2018
At the heart of Sanofi
Integrated Report 2020

Disclaimer: the information presented in this section is not an offer or a sollicitation of an offer to buy, to sell or to subscribe for any Sanofi securities. This information shall not constitue a sollicitation to invest.